The Safety and Efficacy of Mediastinoscopy in Non-small Cell Lung Cancer

비소세포폐암에서 종격동경검사의 안전성과 유용성

  • Park In-Kyu (Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine) ;
  • Cho Sang-Ho (Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine) ;
  • Kim Dae-Joon (Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine) ;
  • Chung Kyung-Young (Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine)
  • 박인규 (연세대학교 의과대학 흉부외과학교실) ;
  • 조상호 (연세대학교 의과대학 흉부외과학교실) ;
  • 김대준 (연세대학교 의과대학 흉부외과학교실) ;
  • 정경영 (연세대학교 의과대학 흉부외과학교실)
  • Published : 2006.06.01

Abstract

Background: Mediastinal lymph node metastasis is an important factor for staging and prognosis of non-small cell lung cancer (NSCLC), so accurate diagnosis is essential for treatment. Mediastinoscopy provides histopathological diagnosis of mediastinal lymphnode metastasis in NSCLC. The efficacy of mediastinoscopy was investigated. Material and Method: From Jun, 1999 to Aug, 2005, mediastinoscopic lymph node biopsy was performed to 348 patients with NSCLC. Patients characteristics, radiologic findings, mediastinoscopic results and pathologic stages were evaluated for investigation of safety and efficacy of modiastinoscopy in NSCLC. Result: There was 263 male and 85 female patients and the mean age was $62.1{\pm}8.5$ years. By radiologic study for mediastinal lymph node metastasis, 203 patients were negative and 145 patients were positive. Mean procedure time was $55.5{\pm}16.5$ minutes and biopsy was peformed at $2.2{\pm}1.0$ lymph node stations. There were only transient complications (1.7%) during the procedure, without other complication and mortality. There was 7.8% of false negative result in mediastinoscopy. Sensitivity (77.5% vs 71.9%, p=0.012), specificity (100% vs 74.4%, p=0.00), and accuracy (92.2% vs 73.6%, p=0.00) of mediastinoscopy were more superior than that of radiologic study for the diagnosis of mediastinal lymph node metastasis in NSCLC. Conclusion: Mediastinoscopy is a safe and effective modality for diagnosis of mediastinal lymph node metastasis in NSCLC.

배경: 종격동 림프절 전이 여부는 비소세포폐암의 병기 결정과 예후에 중요한 인자이며, 정확한 진단이 치료 방법결정에 필수적이다. 종격동경검사는 조직병리학적으로 종격동 림프절 전이 여부를 진단할 수 있는 방법으로, 그 유용성에 대해 알아보고자 하였다. 대상 및 방법: 1999년 6월부터 2005년 8월까지 비소세포폐암으로 진단 받고 종격동경검사를 시행하였던 환자 348명을 대상으로 환자의 특성, 방사선학적 검사 결과, 종격동경검사 결과 및 최종 병리학적 병기 등을 후향적으로 조사하여 종격동경검사의 안전성과 유용성을 평가하였다. 결과: 연구대상 환자 348명 중 남자가 263명 여자가 85명이었고 평균 연령은 $62.1{\pm}8.5$세이었다. 203명은 방사선검사에서 종격동 림프절 전이가 없는 것으로 진단되었고 145명에서는 전이가 있는 것으로 진단되었다. 종격동경검사에 걸린 시간은 평균 $55.5{\pm}16.5$분이었고, 평균 $2.2{\pm}1.0$개의 림프절군에서 생검을 하였다. 검사 중 5예(1.7%)의 일시적인 합병증이 발생하였으나, 그 외의 합병증이나 사망은 없었다. 종격동경검사의 위음성률은 7.8%였다. 종격 동경검사는 민감도(77.5% vs 71.9%, p=0.012), 특이도(100% vs 74.4%, p=0.00) 및 정확도(92.2% vs 73.6%, p=0.00) 등이 방사선 검사에 비해 유의하게 높았다. 결론: 종격동경검사는 절제가능한 비소세포폐암에서 치료 전 종격동 림프절 전이 여부에 대해 진단할 수 있는 안전하고 효과적인 방법이다.

Keywords

References

  1. Rosell R, Gomez-Codina J, Camps C, et al. Preresectional chemotherapy in stage IlIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial. Lung Cancer 1999;47:7-14
  2. Betticher DC, Schmiz SFH, Totsh M, et al. Mediastinal lymph node clearance after Doxetaxel-Cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial. J Clin Oncol 2003;21:1752-9 https://doi.org/10.1200/JCO.2003.11.040
  3. Port JL, Karst RJ, Lee PC, et al. Surgical resection for residual N2 disease after induction chemotherapy. Ann Thorac Surg 2005;79:1686-90 https://doi.org/10.1016/j.athoracsur.2004.10.057
  4. Berghmans T, Paesmans M, Meert AP, et al. Survival improvement in resectable non-small cell lung cancer with (neo) adjuvant chemotherapy: reults of a meta-analysis of the literature. Lung Cancer 2005;49:13-23 https://doi.org/10.1016/j.lungcan.2005.01.002
  5. Kimura H, Iwai N, Ando A, et al. A prospective study of indications for mediastinoscqry in lung cancer with CT findings, tumor size, and tumor markers. Ann Thorac Surg 2003;75:1734-9 https://doi.org/10.1016/S0003-4975(03)00035-3
  6. Smolders SA, Smeenk F, Janssen-Heijen M, et al. Surgical mediastinal staging in daily practice. Lung Cancer 2005;47: 243-51 https://doi.org/10.1016/j.lungcan.2004.06.017
  7. De Leyn P, Vansteenkiste J, Cuypers P, et al. Role of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scan. Eur J Cardiothorac Surg 1997;12:706-12 https://doi.org/10.1016/S1010-7940(97)00253-4
  8. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovsc Surg 1978;76:833-9
  9. Mountain CF. Revisions in the internaional system for staging lung cancer. Chest 1997;111:1710-17 https://doi.org/10.1378/chest.111.6_Supplement.111S
  10. Gupta NC, Tamin WJ, Graeber GG, Bishop HA, Hobbs GR. Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging. Chest 2001;120:521-27 https://doi.org/10.1378/chest.120.1.120
  11. Pieterman RM, van Putten JWG, Meuzelaar JJM, et al. Preoperative staging of non-small cell lung cancer with positronemission tomography. N Engl J Med 200;343:254-61 https://doi.org/10.1056/NEJM200007273430404
  12. Cerfolio R, Ojha B, Bryant AS, et al. The role of FDG-PET scan in staging patients with nonsmall cell carcinoma. Ann Thorac Surg 2003;76:861-6 https://doi.org/10.1016/S0003-4975(03)00888-9
  13. Kramer H, Groen HJM. Current concepts in the mediastinal lymph node staging of nonsmall cell lung cancer. Ann Surg 2003;238:180-88
  14. Hoffman H. Invasive staging of lung cancer by mediastinoscopy and video-assisted thoracoscopy. Lung Cancer 2001;34: S3-5
  15. Hammoud ZT, Anderson RC, Meyers BF, et al. The current role of mediastinoscopy in the evaluation of thoracic disease. J Thorac Cardiovasc Surg 1999;118:894-9 https://doi.org/10.1016/S0022-5223(99)70059-0
  16. Venissac N, Alifano M, Mouroux J. Video-assisted mediastinoscopy: experience fran 240 consecutive cases. Ann Thorac Surg 2003;76:208-12 https://doi.org/10.1016/S0003-4975(03)00164-4